Abstract:Objective: Anesthetic preconditioning appears to be a viable strategy to treat ischemic cerebral injury. Here we investigated 1) whether the protection conferred by sevoflurane preconditioning sustains in time; 2) whether sevoflurane preconditioning diminishes mitochondrial dysfunction following cerebral ischemia; and 3) whether mitochondrial permeability transition pore plays a crucial role in the sevoflurane preconditioning.Design: Laboratory investigation.Setting: University research laboratory.Subjects: Sprague-Dawley rats.Interventions: Rats underwent 2 hrs of focal cerebral ischemia induced by middle cerebral artery occlusion. Preconditioning was elicited with sevoflurane (2.3%) for 60 mins at 24 hrs before ischemia. The involvement of mitochondrial permeability transition pore was determined with a mitochondrial permeability transition pore opener atractyloside and a specific mitochondrial permeability transition pore inhibitor cyclosporin A. In vitro study was performed on acutely isolated mitochondria subjected to calcium overload.Measurements and Main Results: Sevoflurane preconditioning significantly decreased the infarct size by 35.9% (95% confidence interval 6.5-28.4, p < .001). This reduction of injury volume was associated with a long-term improvement of neurological function according to modified neurological severity score (F = 13.6, p = .001) and sticky-tape test (F = 29.1, p < .001) for 42 days after ischemia. Furthermore, sevoflurane preconditioning markedly protected mitochondria, as indicated by preserved respiratory chain complex activities and membrane potential, lowered mitochondrial hydrogen-peroxide production, and attenuated mitochondrial permeability transition pore opening. Isolated mitochondria also demonstrated a reduced sensitivity to Ca2+-induced mitochondrial permeability transition pore opening after pre-exposure to sevoflurane in vitro (95% confidence interval 24.2-196.5, p = .006). Inhibiting mitochondrial permeability transition pore using cyclosporin A resulted in protective effects similar to those seen with sevoflurane preconditioning, whereas pharmacologically opening the mitochondrial permeability transition pore with atractyloside abrogated all the positive effects of sevoflurane preconditioning and cyclosporin A, including suppression of mitochondrial permeability transition pore opening, counteraction of mitochondria-dependent apoptotic pathway, and subsequent histological and behavioral improvements.Conclusions: Sevoflurane preconditioning protects mitochondria from cerebral ischemia/reperfusion injury and ameliorates long-term neurological deficits. Inhibition of mitochondrial permeability transition pore opening is a crucial step in mediating the neuroprotection of sevoflurane preconditioning. (Crit Care Med 2012; 40:2685-2693)

Postconditioning of Sevoflurane and Propofol is Associated with Mitochondrial Permeability Transition Pore

[Sevoflurane Postconditioning Attenuates Myocardial Apoptosis in Isolated Rat Hearts Via a Modulation of Bcl-2 Family Proteins].

Sevoflurane Postconditioning Reduces Myocardial Reperfusion Injury in Rat Isolated Hearts Via Activation of PI3K/Akt Signaling and Modulation of Bcl-2 Family Proteins.

Effects of sevoflurane postconditioning on myocardial ischemia-reperfusion-induced oncosis of cardiomyocytes in rats: relationship with mitochondrial permeability transition pore

Effects of Sevoflurane Preconditioning and Postconditioning on Rat Myocardial Stunning in Ischemic Reperfusion Injury

Postconditioning with Sevoflurane Protects Against Focal Cerebral Ischemia and Reperfusion Injury Via Pi3k/Akt Pathway

Effect of sevoflurane preconditioning on mitochondrial permeability transition pore following focal cerebral ischemia-reperfusion injury in rats

Sevoflurane Postconditioning Converts Persistent Ventricular Fibrillation into Regular Rhythm

Sevoflurane Preconditioning Improves Mitochondrial Function And Long-Term Neurologic Sequelae After Transient Cerebral Ischemia: Role Of Mitochondrial Permeability Transition

Role of Mitochondrial ATP-sensitive Potassium Channel-Mediated PKC-ε in Delayed Protection Against Myocardial Ischemia/reperfusion Injury in Isolated Hearts of Sevoflurane-Preconditioned Rats

Sevoflurane postconditioning converts persistent ventricular fibrillation into regular rhythm.

Role of mitochondrial ATP-sensitive potassium channel in sevoflurane preconditioning-induced delayed cardioprotection against ischemia-reperfusion injury in isolated rat hearts

Cardioprotection of sevoflurane postconditioning on isolated rat hearts

Activation of Akt and Cardioprotection Against Reperfusion Injury Are Maximal with Only Five Minutes of Sevoflurane Postconditioning in Isolated Rat Hearts

Blocking Effects of Lidocaine on Sevoflurane Postconditioning-Induced Myocardial Protection in Rats

Lidocaine Abolishes the Myocardial Protective Effect of Sevoflurane Post‐conditioning

Effects of sufentanil postconditioning and sevoflurane postconditioning on myocardial ischemia/reperfusion injury in isolated rat hearts

Sevoflurane Post-Conditioning Reduces Rat Myocardial Ischemia Reperfusion Injury Through An Increase In Nos And A Decrease In Phopshorylated Nhe1 Levels

Effects of sevoflurane postconditioning on mitophagy during ischemia-reperfusion in rats

Role of mitochondrial ATP-sensitive potassium channel in sevoflurane preconditioning-reduced focal cerebral ischemia-reperfusion injury in rats

Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signals.